Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 10.07.15 in Vol 17, No 7 (2015): July

This paper is in the following e-collection/theme issue:

Works citing "Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review"

According to Crossref, the following articles are citing this article (DOI 10.2196/jmir.4304):

(note that this is only a small subset of citations)

  1. Li X, Lin X, Ren H, Guo J. Ontological Organization and Bioinformatic Analysis of Adverse Drug Reactions From Package Inserts: Development and Usability Study. Journal of Medical Internet Research 2020;22(7):e20443
    CrossRef
  2. Karapetiantz P, Bellet F, Audeh B, Lardon J, Leprovost D, Aboukhamis R, Morlane-Hondère F, Grouin C, Burgun A, Katsahian S, Jaulent M, Beyens M, Lillo-Le Louët A, Bousquet C. Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions. Frontiers in Pharmacology 2018;9
    CrossRef
  3. Pierce CE, Bouri K, Pamer C, Proestel S, Rodriguez HW, Van Le H, Freifeld CC, Brownstein JS, Walderhaug M, Edwards IR, Dasgupta N. Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. Drug Safety 2017;40(4):317
    CrossRef
  4. Convertino I, Ferraro S, Blandizzi C, Tuccori M. The usefulness of listening social media for pharmacovigilance purposes: a systematic review. Expert Opinion on Drug Safety 2018;17(11):1081
    CrossRef
  5. Hughes S, Lacasse JR, Spaulding-Givens J. The micro-to-macro realities of antidepressant taking: Users’ experiences in the context of contested science and industry promotion. Qualitative Social Work 2020;19(5-6):1219
    CrossRef
  6. Alimova IS, Tutubalina EV. Entity-Level Classification of Adverse Drug Reaction: A Comparative Analysis of Neural Network Models. Programming and Computer Software 2019;45(8):439
    CrossRef
  7. Wang W, Cheung BC, Leung ZC, Chan K, See-To EW. A Social Media Mining and Analysis Approach for Supporting Cyber Youth Work. International Journal of Knowledge and Systems Science 2017;8(2):1
    CrossRef
  8. Kheloufi F, Default A, Blin O, Micallef J. Investigating patient narratives posted on Internet and their informativeness level for pharmacovigilance purpose: The example of comments about statins. Therapies 2017;72(4):483
    CrossRef
  9. Raghupathi V, Zhou Y, Raghupathi W. Exploring Big Data Analytic Approaches to Cancer Blog Text Analysis. International Journal of Healthcare Information Systems and Informatics 2019;14(4):1
    CrossRef
  10. Pappa D, Stergioulas LK. Harnessing social media data for pharmacovigilance: a review of current state of the art, challenges and future directions. International Journal of Data Science and Analytics 2019;8(2):113
    CrossRef
  11. Tutubalina EV, Miftahutdinov ZS, Nugmanov RI, Madzhidov TI, Nikolenko SI, Alimova IS, Tropsha AE. Using semantic analysis of texts for the identification of drugs with similar therapeutic effects. Russian Chemical Bulletin 2017;66(11):2180
    CrossRef
  12. Gachloo M, Wang Y, Xia J. A review of drug knowledge discovery using BioNLP and tensor or matrix decomposition. Genomics & Informatics 2019;17(2):e18
    CrossRef
  13. Zhou L, Zhang D, Yang CC, Wang Y. Harnessing social media for health information management. Electronic Commerce Research and Applications 2018;27:139
    CrossRef
  14. Krallinger M, Rabal O, Lourenço A, Oyarzabal J, Valencia A. Information Retrieval and Text Mining Technologies for Chemistry. Chemical Reviews 2017;117(12):7673
    CrossRef
  15. Safarnejad L, Xu Q, Ge Y, Bagavathi A, Krishnan S, Chen S. Identifying Influential Factors in the Discussion Dynamics of Emerging Health Issues on Social Media: Computational Study. JMIR Public Health and Surveillance 2020;6(3):e17175
    CrossRef
  16. Abdellaoui R, Schück S, Texier N, Burgun A. Filtering Entities to Optimize Identification of Adverse Drug Reaction From Social Media: How Can the Number of Words Between Entities in the Messages Help?. JMIR Public Health and Surveillance 2017;3(2):e36
    CrossRef
  17. Abdellaoui R, Foulquié P, Texier N, Faviez C, Burgun A, Schück S. Detection of Cases of Noncompliance to Drug Treatment in Patient Forum Posts: Topic Model Approach. Journal of Medical Internet Research 2018;20(3):e85
    CrossRef
  18. Liu Y, Shi J, Chen Y. Patient‐centered and experience‐aware mining for effective adverse drug reaction discovery in online health forums. Journal of the Association for Information Science and Technology 2018;69(2):215
    CrossRef
  19. Kalf RR, Makady A, ten Ham RM, Meijboom K, Goettsch WG. Use of Social Media in the Assessment of Relative Effectiveness: Explorative Review With Examples From Oncology. JMIR Cancer 2018;4(1):e11
    CrossRef
  20. Powell GE, Seifert HA, Reblin T, Burstein PJ, Blowers J, Menius JA, Painter JL, Thomas M, Pierce CE, Rodriguez HW, Brownstein JS, Freifeld CC, Bell HG, Dasgupta N. Social Media Listening for Routine Post-Marketing Safety Surveillance. Drug Safety 2016;39(5):443
    CrossRef
  21. Correia RB, Wood IB, Bollen J, Rocha LM. Mining Social Media Data for Biomedical Signals and Health-Related Behavior. Annual Review of Biomedical Data Science 2020;3(1):433
    CrossRef
  22. Sinnenberg L, Buttenheim AM, Padrez K, Mancheno C, Ungar L, Merchant RM. Twitter as a Tool for Health Research: A Systematic Review. American Journal of Public Health 2017;107(1):e1
    CrossRef
  23. Audeh B, Beigbeder M, Zimmermann A, Jaillon P, Bousquet C, Choo KR. Vigi4Med Scraper: A Framework for Web Forum Structured Data Extraction and Semantic Representation. PLOS ONE 2017;12(1):e0169658
    CrossRef
  24. Bousquet C, Dahamna B, Guillemin-Lanne S, Darmoni SJ, Faviez C, Huot C, Katsahian S, Leroux V, Pereira S, Richard C, Schück S, Souvignet J, Lillo-Le Louët A, Texier N. The Adverse Drug Reactions from Patient Reports in Social Media Project: Five Major Challenges to Overcome to Operationalize Analysis and Efficiently Support Pharmacovigilance Process. JMIR Research Protocols 2017;6(9):e179
    CrossRef
  25. Li F, Liu W, Yu H. Extraction of Information Related to Adverse Drug Events from Electronic Health Record Notes: Design of an End-to-End Model Based on Deep Learning. JMIR Medical Informatics 2018;6(4):e12159
    CrossRef
  26. Chen X, Faviez C, Schuck S, Lillo-Le-Louët A, Texier N, Dahamna B, Huot C, Foulquié P, Pereira S, Leroux V, Karapetiantz P, Guenegou-Arnoux A, Katsahian S, Bousquet C, Burgun A. Mining Patients' Narratives in Social Media for Pharmacovigilance: Adverse Effects and Misuse of Methylphenidate. Frontiers in Pharmacology 2018;9
    CrossRef
  27. Dai H, Touray M, Jonnagaddala J, Syed-Abdul S. Feature Engineering for Recognizing Adverse Drug Reactions from Twitter Posts. Information 2016;7(2):27
    CrossRef
  28. Abbasi A, Li J, Abbasi S, Adjeroh D, Abate M, Zheng W. Don't Mention It? Analyzing User-Generated Content Signals for Early Adverse Drug Event Warnings. SSRN Electronic Journal 2015;
    CrossRef
  29. Lardon J, Bellet F, Aboukhamis R, Asfari H, Souvignet J, Jaulent M, Beyens M, Lillo-LeLouët A, Bousquet C. Evaluating Twitter as a complementary data source for pharmacovigilance. Expert Opinion on Drug Safety 2018;17(8):763
    CrossRef
  30. Karapetiantz P, Lillo-Le Louët A, Bousquet C. Informativité des forums de discussion français pour l’évaluation des effets indésirables du baclofène. Therapies 2019;74(6):569
    CrossRef
  31. Jagannatha A, Liu F, Liu W, Yu H. Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0). Drug Safety 2019;42(1):99
    CrossRef
  32. Audeh B, Bellet F, Beyens M, Lillo-Le Louët A, Bousquet C. Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project. Drug Safety 2020;43(9):835
    CrossRef
  33. Bravo , Li TS, Su AI, Good BM, Furlong LI. Combining machine learning, crowdsourcing and expert knowledge to detect chemical-induced diseases in text. Database 2016;2016:baw094
    CrossRef
  34. Sinha MS, Freifeld CC, Brownstein JS, Donneyong MM, Rausch P, Lappin BM, Zhou EH, Dal Pan GJ, Pawar AM, Hwang TJ, Avorn J, Kesselheim AS. Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis. JMIR Public Health and Surveillance 2018;4(1):e1
    CrossRef
  35. Munkhdalai T, Liu F, Yu H. Clinical Relation Extraction Toward Drug Safety Surveillance Using Electronic Health Record Narratives: Classical Learning Versus Deep Learning. JMIR Public Health and Surveillance 2018;4(2):e29
    CrossRef
  36. Abbasi A, Li J, Adjeroh D, Abate M, Zheng W. Don’t Mention It? Analyzing User-Generated Content Signals for Early Adverse Event Warnings. Information Systems Research 2019;30(3):1007
    CrossRef
  37. Sutphin C, Lee K, Yepes AJ, Uzuner , McInnes BT. Adverse drug event detection using reason assignments in FDA drug labels. Journal of Biomedical Informatics 2020;110:103552
    CrossRef
  38. Topaz M, Lai K, Dhopeshwarkar N, Seger DL, Sa’adon R, Goss F, Rozenblum R, Zhou L. Clinicians’ Reports in Electronic Health Records Versus Patients’ Concerns in Social Media: A Pilot Study of Adverse Drug Reactions of Aspirin and Atorvastatin. Drug Safety 2016;39(3):241
    CrossRef
  39. . Big Data’s Role in Precision Public Health. Frontiers in Public Health 2018;6
    CrossRef
  40. Bhattacharya M, Snyder S, Malin M, Truffa MM, Marinic S, Engelmann R, Raheja RR. Using Social Media Data in Routine Pharmacovigilance: A Pilot Study to Identify Safety Signals and Patient Perspectives. Pharmaceutical Medicine 2017;31(3):167
    CrossRef
  41. Turner JR, Kowey PR, Rodriguez I, Cabell CH, Gintant G, Green CL, Kunz BL, Mortara J, Sager PT, Stockbridge N, Wright TJ, Finkle J, Krucoff MW. The Cardiac Safety Research Consortium enters its second decade: An invitation to participate. American Heart Journal 2016;177:96
    CrossRef
  42. Bollegala D, Maskell S, Sloane R, Hajne J, Pirmohamed M. Causality Patterns for Detecting Adverse Drug Reactions From Social Media: Text Mining Approach. JMIR Public Health and Surveillance 2018;4(2):e51
    CrossRef
  43. Smith K, Golder S, Sarker A, Loke Y, O’Connor K, Gonzalez-Hernandez G. Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab. Drug Safety 2018;41(12):1397
    CrossRef
  44. Tricco AC, Zarin W, Lillie E, Jeblee S, Warren R, Khan PA, Robson R, Pham B, Hirst G, Straus SE. Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review. BMC Medical Informatics and Decision Making 2018;18(1)
    CrossRef
  45. Borchert JS, Wang B, Ramzanali M, Stein AB, Malaiyandi LM, Dineley KE. Adverse Events Due to Insomnia Drugs Reported in a Regulatory Database and Online Patient Reviews: Comparative Study. Journal of Medical Internet Research 2019;21(11):e13371
    CrossRef
  46. Audeh B, Calvier F, Bellet F, Beyens M, Pariente A, Lillo-Le Louet A, Bousquet C. Pharmacology and social media: Potentials and biases of web forums for drug mention analysis—case study of France. Health Informatics Journal 2020;26(2):1253
    CrossRef
  47. Pathak R, Catalan-Matamoros D. Can Twitter posts serve as early indicators for potential safety signals? A retrospective analysis. International Journal of Risk & Safety in Medicine 2023;34(1):41
    CrossRef
  48. Coca JR, Coca-Asensio R, Esteban Bueno G. Socio-historical analysis of the social importance of pharmacovigilance. Frontiers in Sociology 2022;7
    CrossRef
  49. Dirkson A, den Hollander D, Verberne S, Desar I, Husson O, van der Graaf WTA, Oosten A, Reyners AKL, Steeghs N, van Loon W, van Oortmerssen G, Gelderblom H, Kraaij W. Sample Bias in Web-Based Patient-Generated Health Data of Dutch Patients With Gastrointestinal Stromal Tumor: Survey Study. JMIR Formative Research 2022;6(12):e36755
    CrossRef
  50. Takats C, Kwan A, Wormer R, Goldman D, Jones HE, Romero D. Ethical and Methodological Considerations of Twitter Data for Public Health Research: Systematic Review. Journal of Medical Internet Research 2022;24(11):e40380
    CrossRef
  51. Walsh J, Dwumfour C, Cave J, Griffiths F. Spontaneously generated online patient experience data - how and why is it being used in health research: an umbrella scoping review. BMC Medical Research Methodology 2022;22(1)
    CrossRef
  52. Dirkson A, Verberne S, Kraaij W, van Oortmerssen G, Gelderblom H. Automated gathering of real-world data from online patient forums can complement pharmacovigilance for rare cancers. Scientific Reports 2022;12(1)
    CrossRef
  53. . Computing Drug-Drug Similarity from Patient-Centric Data. Bioengineering 2023;10(2):182
    CrossRef
  54. Fossouo Tagne J, Yakob RA, Dang TH, Mcdonald R, Wickramasinghe N. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review. JMIR Public Health and Surveillance 2023;9:e40080
    CrossRef
  55. Gordijn R, Wessels W, Kriek E, Nicolai MPJ, Elzevier HW, Visser L, Guchelaar H, Teichert M. Patient reporting of sexual adverse events on an online platform for medication experiences. British Journal of Clinical Pharmacology 2022;88(12):5326
    CrossRef
  56. Yahya AA, Asiri Y, Alyami I, Asghar MZ. Social Media Analytics for Pharmacovigilance of Antiepileptic Drugs. Computational and Mathematical Methods in Medicine 2022;2022:1
    CrossRef
  57. Park S, Choi SH, Song Y, Kwon J. Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study. JMIR Public Health and Surveillance 2022;8(1):e33311
    CrossRef
  58. Khademi Habibabadi S, Palmer C, Dimaguila GL, Javed M, Clothier HJ, Buttery J. Australasian Institute of Digital Health Summit 2022–Automated Social Media Surveillance for Detection of Vaccine Safety Signals: A Validation Study. Applied Clinical Informatics 2023;14(01):01
    CrossRef
  59. Shakeri Hossein Abad Z, Butler GP, Thompson W, Lee J. Crowdsourcing for Machine Learning in Public Health Surveillance: Lessons Learned From Amazon Mechanical Turk. Journal of Medical Internet Research 2022;24(1):e28749
    CrossRef
  60. Khademi Habibabadi S, Delir Haghighi P, Burstein F, Buttery J. Vaccine Adverse Event Mining of Twitter Conversations: 2-Phase Classification Study. JMIR Medical Informatics 2022;10(6):e34305
    CrossRef
  61. Keller R, Spanu A, Puhan MA, Flahault A, Lovis C, Mütsch M, Beau-Lejdstrom R. Social media and internet search data to inform drug utilization: A systematic scoping review. Frontiers in Digital Health 2023;5
    CrossRef
  62. Roche V, Robert J, Salam H. AI-Based Approach for Safety Signals Detection from Social Networks: Application to the Levothyrox Scandal in 2017 on Doctissimo Forum. SSRN Electronic Journal 2021;
    CrossRef
  63. Golder S, O'Connor K, Wang Y, Gonzalez Hernandez G. The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review. JMIR Research Protocols 2023;12:e47068
    CrossRef
  64. Roche V, Robert J, Salam H. A holistic AI-based approach for pharmacovigilance optimization from patients behavior on social media. Artificial Intelligence in Medicine 2023;144:102638
    CrossRef
  65. Nwagwu W, Olayanju O. Aspects of Quality and Reliability of Ebola Virus Disease Information on Facebook. Mousaion: South African Journal of Information Studies 2023;41(1)
    CrossRef
  66. Lu Q, Schulz PJ, Chang A. Medication safety perceptions in China: Media exposure, healthcare experiences, and trusted information sources. Patient Education and Counseling 2024;123:108209
    CrossRef
  67. Wessel D, Pogrebnyakov N. Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making. Drug Safety 2024;
    CrossRef

According to Crossref, the following books are citing this article (DOI 10.2196/jmir.4304):

  1. Dasgupta N, Winokur C, Pierce C. Communicating about Risks and Safe Use of Medicines. 2020. Chapter 11:307
    CrossRef
  2. Wang W, Cheung BC, Leung ZC, Chan K, See-To EW. Multigenerational Online Behavior and Media Use. 2019. chapter 92:1737
    CrossRef
  3. Alimova I, Tutubalina E. Analysis of Images, Social Networks and Texts. 2018. Chapter 1:3
    CrossRef
  4. Alasmari A, Zhou L. Social Computing and Social Media. Communication and Social Communities. 2019. Chapter 7:79
    CrossRef
  5. Hasan SA, Farri O. Data Science for Healthcare. 2019. Chapter 5:147
    CrossRef
  6. Motulsky A, Nikiema J, Bosson-Rieutort D. Multiple Perspectives on Artificial Intelligence in Healthcare. 2021. Chapter 8:91
    CrossRef
  7. Raghupathi V, Zhou Y, Raghupathi W. Research Anthology on Big Data Analytics, Architectures, and Applications. 2022. chapter 90:1843
    CrossRef